glp-1 ibd Relevance of Glucagon-Like Peptide 1 (GLP-1) in Inflammatory Bowel Diseases: A Narrative Review glp 1 ibd Effects of

Therefore, it is advisable for people to discuss the potential risk and benefits of GLP-1 medications with their healthcare providers

GLP-1 is normally secreted by L cells of the gastrointestinal mucosa in response to a meal

Safety first: when to call your clinician GLP-1 medications are generally well tolerated, but like with any treatment, side effects can occur

Abeer MM, Meka AK, Pujara N, Kumeria T, Strounina E, Nunes R, et al

The present study findings will not only help clinical care but also guide future mechanistic and clinical research to evaluate the broad pleiotropic effects of GLP-1RAs

Safety and Tolerability in Early AOM Use The safety profile of anti-obesity medications (AOMs) requires careful consideration when implementing early intervention strategies for GLP-1 non-responders